Page last updated: 2024-08-23

simvastatin and Benign Paroxysmal Peritonitis

simvastatin has been researched along with Benign Paroxysmal Peritonitis in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Carlucci, JG; Edwards, KM; Wurster, VM1
Drenth, JP; Drewe, E; Kelley, RI; Powell, RJ; Simon, A; Stalenhoef, AF; van der Meer, JW1
Houten, SM; Schneiders, MS; Turkenburg, M; Wanders, RJ; Waterham, HR1

Reviews

1 review(s) available for simvastatin and Benign Paroxysmal Peritonitis

ArticleYear
Periodic Fever syndromes.
    Pediatric annals, 2011, Volume: 40, Issue:1

    Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Child; Colchicine; Cryopyrin-Associated Periodic Syndromes; Cytokines; Diagnosis, Differential; Familial Mediterranean Fever; Fever; Hereditary Autoinflammatory Diseases; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunosuppressive Agents; Lymphadenitis; Mevalonate Kinase Deficiency; Neutropenia; Pharyngitis; Prednisone; Recombinant Fusion Proteins; Recurrence; Simvastatin; Stomatitis, Aphthous; Syndrome

2011

Trials

1 trial(s) available for simvastatin and Benign Paroxysmal Peritonitis

ArticleYear
Simvastatin treatment for inflammatory attacks of the hyperimmunoglobulinemia D and periodic fever syndrome.
    Clinical pharmacology and therapeutics, 2004, Volume: 75, Issue:5

    Topics: Adolescent; Adult; Double-Blind Method; Familial Mediterranean Fever; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypergammaglobulinemia; Male; Mevalonic Acid; Middle Aged; Simvastatin; Syndrome; Treatment Outcome

2004

Other Studies

1 other study(ies) available for simvastatin and Benign Paroxysmal Peritonitis

ArticleYear
Manipulation of isoprenoid biosynthesis as a possible therapeutic option in mevalonate kinase deficiency.
    Arthritis and rheumatism, 2006, Volume: 54, Issue:7

    Topics: Bridged Bicyclo Compounds, Heterocyclic; Cell Line; Familial Mediterranean Fever; Fibroblasts; Gene Expression Regulation, Enzymologic; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunoglobulin D; Phosphotransferases (Alcohol Group Acceptor); RNA, Messenger; Simvastatin; Squalene; Terpenes; Tricarboxylic Acids

2006